Case Report: Effective management of residual glioblastoma with combined modality therapy [PDF]
Frontiers in OncologyGlioblastoma (GBM) is an aggressive primary brain tumor with a poor prognosis, often characterized by rapid progression and resistance to conventional therapies.
Heng-Jui Chang +5 more
doaj +2 more sources
Combined modality therapy of central nervous system tumours [PDF]
, 2001 R Rampling
openalex +4 more sources
Complete remission of metastatic osteosarcoma using combined modality therapy: a retrospective analysis of unselected patients in China. [PDF]
BMC Cancer, 2021 Xie L +11 more
europepmc +3 more sources
Combined modality therapy for exsudative form of age-related macular degeneration
Biomedical Photonics, 2013 Treatment outcomes in patients with age-related vascular degeneration due to formation of subretinal neovascular membrane (SNM) of two groups: photodynamic therapy (PDT) with Photosens alone (18 patients) and in combination with anti-VEGF therapy with ...
М. V. Budzinskaya +6 more
doaj +4 more sources
Management of Locally Advanced Esophageal Cancer
Journal of Nepal Medical Association, 2021 Esophageal cancer is diagnosed usually at a locally advanced stage. Surgery alone has less optimal results and a multimodality approach has been established as the standard of care for cII-III stages of esophageal cancer.
Binay Thakur +2 more
doaj +3 more sources
Improved Management of the Advanced Nonseminomatous Testis Cancer
Revista Brasileira de Cancerologia, 2023 With the VAB-6 program about 90% (54/59) of patients with stage III and bulky stage II disease achieved complete remission and eighty percent remain free of disease.
Davor Vugrin
doaj +1 more source
Combined Modality Therapy Based on Hybrid Gold Nanostars Coated with Temperature Sensitive Liposomes to Overcome Paclitaxel-Resistance in Hepatic Carcinoma. [PDF]
Pharmaceutics, 2019 Zhu H +7 more
europepmc +3 more sources
Survival impact of prolonged postoperative radiation therapy for patients with glioblastoma treated with combined-modality therapy. [PDF]
Neurooncol Pract, 2019 Yusuf MB +4 more
europepmc +3 more sources
The case for combined-modality therapy for limited-stage Hodgkin's disease. [PDF]
Oncologist, 2012 Hill-Kayser CE +3 more
europepmc +3 more sources
Archives of Endocrinology and Metabolism, 2021 Objectives: To evaluate the effectiveness of adding dapagliflozin as an intensification strategy for the treatment of patients with uncontrolled type 2 diabetes mellitus (T2DM). Materials and methods: A historical cohort study was conducted in 123 adult
Vanessa Bedoya Joaqui +7 more
doaj +1 more source